المؤلفون: Accovion GmbH

المصدر: Dschka T, Radny P, Domus R, Mensg H, Brung H, Jenne L, Karl L, Sebastn M, Oster-Schmt C, Klovekorn W, Rehold U, Tanner M, Grone D, Dehmann M, Son M, Hubger F, Hofbauer G, Krahn-Senftleben G, Borrosch F, Reh K, Berkg C, Wolf P, Lehmann P, Moers-CarpM, Honsmann H, Wernke-Panten K, Helw C, Foguet M, Schmz B, Lubbert H, Szes RM; AK-CT002 Study Group. Photodynam therapy wh BF-200 ALA for the treatment of act keratos: results of a multentre, randomed, observer-bld phase study comparon wh a regtered methyl-5-amolaevulate cream and placebo. Br J Dermatol. 2012 Jan;166(1):137-46. do 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.
Dschka T, Radny P, Domus R, Mensg H, Brung H, Jenne L, Karl L, Sebastn M, Oster-Schmt C, Klovekorn W, Rehold U, Tanner M, Grone D, Dehmann M, Son M, Hubger F, Hofbauer G, Krahn-Senftleben G, Borrosch F, Reh K, Berkg C, Wolf P, Lehmann P, Moers-CarpM, Honsmann H, Wernke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmz B, Lubbert H, Szes RM; AK-CT002 Study Group; AK-CT003 Study Group. Long-term (6 and 12 months) follow-up of two prospecte, randomed, controlled phase trls of photodynam therapy wh BF-200 ALA and methyl amolaevulate for the treatment of act keratos. Br J Dermatol. 2013 Apr;168(4):825-36. do 10.1111/bjd.12158.
A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of a Nanoemulsion Gel Formulation BF-200 ALA, in Comparison With Metvix® and Placebo, for the Treatment of Actinic Keratosis With PDT

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02799069Test

المؤلفون: Siro Clinpharm Germany GmbH (until June 2013), Accovion GmbH

المصدر: Long-term Effects of Aldara® 5% Cream and Solaraze® 3% Gel in the Treatment of Actinic Keratoses on the Face or Scalp With Respect to the Risk of Progression to In-situ and Invasive Squamous Cell Carcinoma

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT01453179Test

المؤلفون: ICON plc, SYNLAB Analytics and Services Germany GmbH, Phoenix Clinical Research, Accovion GmbH, Pharmetheus AB

المصدر: A Prospective, Open-label, Phase I/III Study Investigating Pharmacokinetic Properties of BT524 and Efficacy and Safety of BT524 in the Treatment and Prophylaxis of Bleeding in Patients With Congenital Fibrinogen Deficiency

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02065882Test

المؤلفون: Accovion GmbH

المصدر: Morton CA, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Grone D, Schulze HJ, Ockenfels HM, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach P, Gupta G, Hubinger F, Ziabreva I, Schmitz B, Gertzmann A, Lubbert H, Szeimies RM. A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy. Br J Dermatol. 2018 Aug;179(2):309-319. doi: 10.1111/bjd.16441. Epub 2018 May 16.
A Randomized, Observer Blind, Multinational Phase III Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) in Comparison to Metvix® in the Treatment of Non-aggressive Basal Cell Carcinoma (BCC) With Photodynamic Therapy (PDT)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02144077Test

Other URLs: http://www.ncbi.nlm.nih.gov/pubmed/29432644Test

المؤلفون: Accovion GmbH

المصدر: CoolLoop Paroxysmal Atrial Fibrillation

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02553239Test